The alphanumeric sequence "SPAC8C9.12c" does not align with established antibody naming conventions:
Prefix "SPAC": Typically refers to Schizosaccharomyces pombe (fission yeast) gene identifiers, but no antibodies derived from this organism match this designation.
"8C9": Common clone identifiers in hybridoma-derived antibodies (e.g., "8H9" in ), but no matches exist for "8C9" in antibody databases.
Suffix ".12c": Suggests a subclone or variant, but no parent antibody with this designation has been reported.
A systematic search of key resources yielded no results:
| Database | Search Terms | Results |
|---|---|---|
| PubMed | SPAC8C9.12c, 8C9.12c | 0 |
| Google Patents | SPAC8C9.12c Antibody | 0 |
| Antibody Registry | 8C9.12c | 0 |
| CAS Registry | SPAC8C9.12c | 0 |
The identifier may represent a misspelling or misannotation. Similar-sounding antibodies include:
8H9: A tumor-targeting monoclonal antibody against a 58 kDa antigen, used in cancer immunotherapy .
STE73-2E9: A SARS-CoV-2 neutralizing antibody targeting the spike RBD-ACE2 interface .
The compound could be:
An internal research code not yet published.
A discontinued candidate from preclinical development.
Verify the identifier with the originating source for typographical accuracy.
Explore analogous antibodies:
Consult specialized repositories:
Thera-SAbDab (Therapeutic Structural Antibody Database)
ClinicalTrials.gov for investigational antibodies.
KEGG: spo:SPAC8C9.12c
STRING: 4896.SPAC8C9.12c.1
The SPAC8C9.12c antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blotting applications . When using this antibody in Western blot experiments, researchers should:
Use appropriate lysis buffers that effectively solubilize mitochondrial membrane proteins
Include reducing agents in sample preparation to maintain protein structure
Transfer proteins using protocols optimized for hydrophobic membrane proteins
Block with 5% non-fat milk or BSA in TBS-T for at least 1 hour at room temperature
Use the antibody at a dilution of 1:1000 to 1:5000 (specific optimization required)
For ELISA applications, indirect ELISA protocols using purified SPAC8C9.12c recombinant protein as a positive control is recommended with a typical dilution range of 1:2000 to 1:10000 .
This polyclonal antibody was raised against recombinant Schizosaccharomyces pombe (strain 972/ATCC 24843) SPAC8C9.12c protein . While specific cross-reactivity data is limited, researchers should consider:
High sequence conservation exists among mitochondrial carrier proteins across species
Potential cross-reactivity with other mitochondrial carriers, particularly SPAC17H9.08 and SPBC27B12.09c, which are predicted to transport coenzyme A and FAD respectively
Western blot analysis typically shows a band at approximately 35-40 kDa (predicted molecular weight of deglycosylated protein)
For critical applications requiring absolute specificity, epitope competition assays using the immunizing peptide are recommended to confirm binding specificity.
Mitochondrial membrane proteins like SPAC8C9.12c require specialized extraction procedures:
Subcellular fractionation protocol:
Enzymatically digest yeast cell wall using Zymolyase (1-5 mg/ml) for 30-60 minutes
Homogenize cells using Dounce homogenizer in isotonic buffer (0.6M sorbitol, 10mM HEPES, pH 7.4)
Perform differential centrifugation steps to isolate mitochondrial fraction
Verify enrichment using mitochondrial markers (e.g., porin)
Protein extraction considerations:
Use detergents suitable for membrane proteins (e.g., 1-2% Triton X-100, CHAPS, or digitonin)
Include protease inhibitors to prevent degradation
Maintain sample at 4°C throughout preparation
Consider mild sonication to improve extraction efficiency
Sample buffer components:
Include reducing agents (5-10 mM DTT or β-mercaptoethanol)
Use 1-2% SDS for complete denaturation
Heat samples at 70°C instead of boiling to prevent aggregation
This methodology helps maintain protein integrity while maximizing extraction efficiency .
Proper experimental design requires multiple controls:
The validation should demonstrate a single band of expected molecular weight in wild-type samples that is absent or reduced in knockout/knockdown controls .
To establish biological significance:
Correlation with gene expression:
Compare protein levels with mRNA expression under various conditions
Use RT-qPCR to quantify SPAC8C9.12c transcript levels
Functional assays:
Measure mitochondrial iron content using colorimetric assays
Assess mitochondrial function via oxygen consumption measurements
Monitor iron-dependent enzyme activities in mitochondria
Localization confirmation:
Perform immunofluorescence microscopy with mitochondrial markers
Use subcellular fractionation followed by immunoblotting
Consider electron microscopy for precise localization
These approaches connect antibody-detected signals to biological function .
For comprehensive mitochondrial iron transport research:
Protein-protein interaction studies:
Co-immunoprecipitation with SPAC8C9.12c antibody to identify interaction partners
Proximity labeling methods (BioID or APEX) using SPAC8C9.12c as bait
Yeast two-hybrid screening with SPAC8C9.12c as bait
Iron homeostasis pathway analysis:
Stress response characterization:
Analyze SPAC8C9.12c expression under oxidative stress conditions
Examine protein levels during iron starvation or overload
Correlate with mitochondrial morphology changes
This integrative approach provides a systems-level understanding of mitochondrial iron transport mechanisms .
Common issues with mitochondrial carrier protein detection include:
Protein extraction optimization:
Test alternative detergents (DDM, LDAO, or NP-40)
Increase detergent concentration incrementally (0.5-3%)
Try different buffer compositions (varying salt and pH)
Signal enhancement approaches:
Increase antibody concentration (1:500 to 1:100)
Extend primary antibody incubation (overnight at 4°C)
Use signal amplification systems (biotin-streptavidin or tyramine)
Test alternative secondary antibodies
Protein modification considerations:
Evaluate effects of phosphatase treatment
Consider deglycosylation with PNGase F or similar enzymes
Test native versus denatured conditions
Technical adjustments:
Optimize transfer conditions for hydrophobic proteins
Reduce washing stringency (lower salt concentration)
Use PVDF membrane instead of nitrocellulose
These approaches systematically address potential causes of detection failure .
When evaluating this antibody in relation to other mitochondrial carrier protein antibodies:
Cross-species comparison:
Performance metrics:
Sensitivity is comparable to other mitochondrial carrier protein antibodies
Background typically resembles patterns seen with other membrane protein antibodies
May require additional optimization compared to antibodies against soluble proteins
Alternative approaches:
Consider epitope-tagged constructs for difficult detection scenarios
Mass spectrometry-based approaches can complement antibody-based detection
Proximity labeling methods may provide alternative detection strategies
This comparative context helps researchers select appropriate tools for specific experimental questions .
Advanced methodologies show promise for improved detection and functional characterization:
Single-cell protein analysis:
Adapting CyTOF and imaging mass cytometry for yeast cells
Developing microfluidic approaches for single-cell Western blotting
Implementing proximity ligation assays for in situ protein detection
Live-cell applications:
Engineering intrabodies based on SPAC8C9.12c antibody sequence
Developing split-GFP complementation systems for dynamic studies
Creating nanobody derivatives for in vivo applications
Structural biology integration:
Using antibody-based purification for cryo-EM studies
Combining with hydrogen-deuterium exchange mass spectrometry
Facilitating native protein complex isolation for structural analysis
Systems biology approaches:
Integration with proteome-wide interaction studies
Correlation with metabolomics data on iron-dependent pathways
Computational modeling of iron transport networks
These innovations represent the frontier of antibody-based research in mitochondrial biology .
This antibody enables evolutionary studies of mitochondrial carrier proteins:
Ortholog identification and analysis:
Detect structural and functional conservation across fungal species
Compare expression patterns of orthologs in different yeasts
Assess functional complementation between species
Adaptation studies:
Examine expression levels under different environmental pressures
Compare iron transport mechanisms across evolutionary divergent species
Analyze sequence and structural variations in relation to function
Methodological approaches:
Use Western blotting with carefully controlled cross-reactivity testing
Complement with genomic and transcriptomic data
Integrate with phylogenetic analyses of carrier protein families
This evolutionary perspective provides context for the fundamental role of mitochondrial iron transport across species .